BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 12697746)

  • 1. Liver-specific deletion of the NADPH-cytochrome P450 reductase gene: impact on plasma cholesterol homeostasis and the function and regulation of microsomal cytochrome P450 and heme oxygenase.
    Gu J; Weng Y; Zhang QY; Cui H; Behr M; Wu L; Yang W; Zhang L; Ding X
    J Biol Chem; 2003 Jul; 278(28):25895-901. PubMed ID: 12697746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conditional knockout of the mouse NADPH-cytochrome p450 reductase gene.
    Wu L; Gu J; Weng Y; Kluetzman K; Swiatek P; Behr M; Zhang QY; Zhuo X; Xie Q; Ding X
    Genesis; 2003 Aug; 36(4):177-81. PubMed ID: 12929087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transgenic mice with a hypomorphic NADPH-cytochrome P450 reductase gene: effects on development, reproduction, and microsomal cytochrome P450.
    Wu L; Gu J; Cui H; Zhang QY; Behr M; Fang C; Weng Y; Kluetzman K; Swiatek PJ; Yang W; Kaminsky L; Ding X
    J Pharmacol Exp Ther; 2005 Jan; 312(1):35-43. PubMed ID: 15328377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic gene expression changes in mouse models with liver-specific deletion or global suppression of the NADPH-cytochrome P450 reductase gene. Mechanistic implications for the regulation of microsomal cytochrome P450 and the fatty liver phenotype.
    Weng Y; DiRusso CC; Reilly AA; Black PN; Ding X
    J Biol Chem; 2005 Sep; 280(36):31686-98. PubMed ID: 16006652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of a mouse model with a reversible hypomorphic cytochrome P450 reductase gene: utility for tissue-specific rescue of the reductase expression, and insights from a resultant mouse model with global suppression of P450 reductase expression in extrahepatic tissues.
    Wei Y; Zhou X; Fang C; Li L; Kluetzman K; Yang W; Zhang QY; Ding X
    J Pharmacol Exp Ther; 2010 Jul; 334(1):69-77. PubMed ID: 20375200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of cytochrome P450 1A2-mediated metabolism and production of reactive oxygen species by heme oxygenase-1 in rat liver microsomes.
    Reed JR; Cawley GF; Backes WL
    Drug Metab Lett; 2011 Jan; 5(1):6-16. PubMed ID: 20942796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inactivation of the hepatic cytochrome P450 system by conditional deletion of hepatic cytochrome P450 reductase.
    Henderson CJ; Otto DM; Carrie D; Magnuson MA; McLaren AW; Rosewell I; Wolf CR
    J Biol Chem; 2003 Apr; 278(15):13480-6. PubMed ID: 12566435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adaptive hepatic and intestinal alterations in mice after deletion of NADPH-cytochrome P450 Oxidoreductase (Cpr) in hepatocytes.
    Cheng X; Gu J; Klaassen CD
    Drug Metab Dispos; 2014 Nov; 42(11):1826-33. PubMed ID: 25147274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of intestinal cytochrome P450 expression by hepatic cytochrome P450: possible involvement of fibroblast growth factor 15 and impact on systemic drug exposure.
    Zhu Y; Ding X; Fang C; Zhang QY
    Mol Pharmacol; 2014 Jan; 85(1):139-47. PubMed ID: 24184963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A mouse model with liver-specific deletion and global suppression of the NADPH-cytochrome P450 reductase gene: characterization and utility for in vivo studies of cyclophosphamide disposition.
    Gu J; Chen CS; Wei Y; Fang C; Xie F; Kannan K; Yang W; Waxman DJ; Ding X
    J Pharmacol Exp Ther; 2007 Apr; 321(1):9-17. PubMed ID: 17218484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cadmium-mediated inhibition of testicular heme oxygenase activity: the role of NADPH-cytochrome c (P-450) reductase.
    Trakshel GM; Kutty RK; Maines MD
    Arch Biochem Biophys; 1986 Nov; 251(1):175-87. PubMed ID: 3098174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of cholestasis produced by bile duct ligation on hepatic heme and hemoprotein metabolism in rats.
    Schacter BA; Joseph E; Firneisz G
    Gastroenterology; 1983 Feb; 84(2):227-35. PubMed ID: 6401253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between hepatic phenotype and changes in gene expression in cytochrome P450 reductase (POR) null mice.
    Wang XJ; Chamberlain M; Vassieva O; Henderson CJ; Wolf CR
    Biochem J; 2005 Jun; 388(Pt 3):857-67. PubMed ID: 15717863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resolution of the rat brain heme oxygenase activity: absence of a detectable amount of the inducible form (HO-1).
    Trakshel GM; Kutty RK; Maines MD
    Arch Biochem Biophys; 1988 Feb; 260(2):732-9. PubMed ID: 3124761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations in microsomal drug metabolism and heme oxygenase activity in isolated hepatic parenchymal and sinusoidal cells in Murphy-Sturm lymphosarcoma-bearing rats.
    Schacter BA; Kurz P
    Clin Invest Med; 1986; 9(3):150-5. PubMed ID: 3093126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of octamethylcyclotetrasiloxane (D4) as an inducer of rat hepatic microsomal cytochrome P450, UDP-glucuronosyltransferase, and epoxide hydrolase: a 28-day inhalation study.
    McKim JM; Wilga PC; Kolesar GB; Choudhuri S; Madan A; Dochterman LW; Breen JG; Parkinson A; Mast RW; Meeks RG
    Toxicol Sci; 1998 Jan; 41(1):29-41. PubMed ID: 9520339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heme oxygenase-1 and NADPH cytochrome P450 reductase expression in experimental allergic encephalomyelitis: an expanded view of the stress response.
    Emerson MR; LeVine SM
    J Neurochem; 2000 Dec; 75(6):2555-62. PubMed ID: 11080209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downregulation of mouse hepatic CYP3A protein by 3-methylcholanthrene does not require cytochrome P450-dependent metabolism.
    Lee C; Ding X; Riddick DS
    Drug Metab Dispos; 2013 Oct; 41(10):1782-6. PubMed ID: 23846873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic activation of benzo[a]pyrene in vitro by hepatic cytochrome P450 contrasts with detoxification in vivo: experiments with hepatic cytochrome P450 reductase null mice.
    Arlt VM; Stiborová M; Henderson CJ; Thiemann M; Frei E; Aimová D; Singh R; Gamboa da Costa G; Schmitz OJ; Farmer PB; Wolf CR; Phillips DH
    Carcinogenesis; 2008 Mar; 29(3):656-65. PubMed ID: 18204078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of NADPH in the interaction between heme oxygenase-1 and cytochrome P450 reductase.
    Higashimoto Y; Sakamoto H; Hayashi S; Sugishima M; Fukuyama K; Palmer G; Noguchi M
    J Biol Chem; 2005 Jan; 280(1):729-37. PubMed ID: 15516695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.